Cargando…
Nanoparticles in clinical trials of COVID-19: An update
Once the World Health Organization (WHO) declared the COVID-19 (Coronavirus Infectious Disease-19) outbreak to be pandemic, massive efforts have been launched by researchers around the globe to combat this emerging infectious disease. Strategies that must be investigated such as expanding testing ca...
Autores principales: | Rauf, Abdur, Abu-Izneid, Tareq, Khalil, Anees Ahmed, Hafeez, Nabia, Olatunde, Ahmed, Rahman, Md. Mominur, Semwal, Prabhakar, Al-Awthan, Yahya Saleh, Bahattab, Omar Salem, Khan, Ishaq N., Khan, Muhammad Arslan, Sharma, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IJS Publishing Group Ltd. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359769/ https://www.ncbi.nlm.nih.gov/pubmed/35953020 http://dx.doi.org/10.1016/j.ijsu.2022.106818 |
Ejemplares similares
-
Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
por: Rauf, Abdur, et al.
Publicado: (2022) -
In Vivo Anti-Inflammatory, Analgesic, Muscle Relaxant, and Sedative Activities of Extracts from Syzygium cumini (L.) Skeels in Mice
por: Rauf, Abdur, et al.
Publicado: (2022) -
Berberine as a Potential Anticancer Agent: A Comprehensive Review
por: Rauf, Abdur, et al.
Publicado: (2021) -
Phytochemistry and Pharmacological Activities of Dracaena cinnabari Resin
por: Al-Awthan, Yahya S., et al.
Publicado: (2021) -
Antidiabetic Activity of Ficusonolide, a Triterpene
Lactone from Ficus foveolata (Wall.
ex Miq.): In Vitro, In Vivo, and In Silico Approaches
por: Din, Ala Ud, et al.
Publicado: (2021)